B.E

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today. Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

IISERs were created through a proclamation of Ministry of Education, Government of India, to promote quality education and research in science and related areas. The first two IISERs (Pune and Kolkata) were established in 2006. This was followed by an Institute at Mohali (2007), Bhopal & Trivandrum (2008), Tirupati (2015), and Berhampur (2016). IISERs were incorporated as Institutions of National Importance under the umbrella of the NIT (Amendment) Act, 2012 (NIT Act 2007). The Act was further amended in 2014, entitled the NITSER ACT 2014.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

All-India Institute of Medical Sciences was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India; to bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity; and to attain self-sufficiency in Post-graduate Medical Education.

The Laboratory was established in 1941 as a research and production centre, known as Drug Research Laboratory of J&K State and was later taken over by Council of Scientific & Industrial Research (CSIR) of Govt. of India in December 1957 as Regional Research Laboratory, Jammu. In view of its core strength in natural products based drug discovery, the mandate of Institute was redefined in 2005 and its name changed to Indian Institute of Integrative Medicine (IIIM).

The CSIR-Institute of Genomics and Integrative biology (CSIR-IGIB) invites applications from bright young individuals from diverse backgrounds with strong motivation and good academic credentials to pursue research in the frontier areas of modern biology leading to a PhD degree.

IPCA LABORATORIES LIMITED is an Indian multinational pharmaceutical company. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules and sells these formulations domestic and global market. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents.

Center of Innovative and Applied Bioprocessing (CIAB) is an autonomous national institute under Department of Biotechnology (Govt. of India). This futuristic innovation institute of its own kind in the country has a mission of advancing knowledge, leads and emerging technologies/processes relevant to agri-food sector towards applications and products. It aims to link them with societal benefits through catalysing/promoting entrepreneurial action around bioprocesses, bio-products, value-addition to bioproducts etc.

Established on October 1, 1933 as University Department of Chemical Technology (popularly called UDCT) of the University of Bombay (now Mumbai), with the noble intention of advancing India's knowledge reserves in chemical science and technology, the Institute has grown to become a premier (deemed) university devoted to education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.